Maj-Britt Kaltoft PhD
Chief Business Officer
Maj-Britt Kaltoft is a senior business executive with over 25 years of experience in out-licensing, contracting, commercialization partnering in the life science industry. Prior to joining Intravacc, she held several senior international managerial positions in BD, with Nova Nordisk, Nycomed, H. Lundbeck, and the Danish State Serum Institute.
Dr. Kaltoft holds a PhD degree in molecular biology and protein biochemistry from the University of Copenhagen, Denmark and a master’s degree in international business from Seattle University in Washington, USA.
Prof. Dr. Virgil Schijns
Chief Scientific Officer
Prof. Dr. Schijns joined Intravacc in November 2020. He was appointed special Professor in Immunology and Virology at North Carolina State University (NCSU) USA, in 2002, and Guest Professor of Immune Intervention at Wageningen University, The Netherlands, Department Cell Biology & Immunology in 2008. Since 2013, he has been Guest Professor at Strathclyde University, Glasgow, United Kingdom.
Virgil also has extensive experience in the Life Science and Biotech sector. He is the CSO of Epitopoietic Research Corporation S.A. in Namur, Belgium. Before that, he was principal Immunologist of Nobilon and Head of Vaccine Technology and Immunology at Intervet-AKZONOBEL.
Daniëlle Lankveld, DVM, PhD
Chief Operating Officer
Daniëlle is Chief Operational Officer of Intravacc since 2017. As a doctor in veterinary medicine she started her career in 1995 as a resident in equine surgery at the former Department of General and Large Animal Surgery of the Utrecht University. After completing this she continued her career as a veterinary anesthetist for the same department and obtained her PhD in 2007. In this year she moved to the National Institute of Public Health to work as both a researcher in nanotoxicology and an assessor of human medical dossiers for cardiovascular medicine. In 2011 Daniëlle became Manager of the Animal Research Center of the former Netherlands Vaccine Institute and member of the management team. In 2013, when the Animal Research Center became part of Intravacc, Daniëlle moved to the position of Chief Development Officer until 2017 when she became the COO.
Join our Community
Are you interested in becoming part of an innovative community, to learn alongside top scientists, to work with state-of-the art equipment, to get an inside look of and contribute to the biotech sector, where industry leaders, government, universities and international non-governmental organizations collaborate? Then Intravacc is the place for you.
Subscribe to our news update
Stay up to date with the latest developments, and be the first to receive our news updates and announcements.